Sri Lanka Bans Four Years Of Medicines Supplied By Four India Makers
This article was originally published in PharmAsia News
Sri Lanka has blacklisted four India drug makers, Bafna, Elysium Pharma, Laborate and Vivek it said supplied substandard medicines.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.